Lv3
344 积分 2025-08-07 加入
Advancing Design Strategy of PROTACs for Cancer Therapy
12天前
已关闭
Targeting Multiple KRAS Mutations with High-Affinity Macrocyclic Inhibitors: From Discovery to Preclinical Validation
20天前
已完结
“Keep on ROCKIn”: Repurposed ROCK inhibitors to boost corneal endothelial regeneration
22天前
已完结
Discovery of unglycosylated indolocarbazoles as ROCK2 isoform-selective inhibitors for the treatment of breast cancer metastasis
24天前
已完结
Protein-templated synthesis of dinucleotide repeat DNA by an antiphage reverse transcriptase
29天前
已完结
ROCK-2-selective targeting and its therapeutic outcomes
1个月前
已完结
Target identification and assessment in the era of AI
1个月前
已完结
Characteristic roadmap of linker governs the rational design of PROTACs
1个月前
已完结
Discovery of (S)-6-methoxy-chroman-3-carboxylic acid (4-pyridin-4-yl-phenyl)-amide as potent and isoform selective ROCK2 inhibitors
1个月前
已关闭
In Situ PROTAC Synthesis Enabled by Pathologically Activated Bioorthogonal Catalysis for Precision Cancer Therapy
2个月前
已完结
皖公网安备34019202002308
